id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-308673-dkmpayk4	Ni, Li	Combination of western medicine and Chinese traditional patent medicine in treating a family case of COVID-19 in Wuhan	2020-03-13		.txt	text/plain	1701	93	59	Here we report the first family case of coronavirus disease 2019 (COVID-19) confirmed in Wuhan and treated using the combination of western medicine and Chinese traditional patent medicine Shuanghuanglian oral liquid (SHL). The present report described a family case, including three cases who received western medicine and Chinese traditional patent medicine Shuanghuanglian oral liquid (SHL) treatments and achieved rapid recovery. On January 28, the patient was diagnosed of COVID-19 with positive 2019-nCoV test using nasopharyngeal swab specimen (Table 1 ) and chest CT scan showing patchy ground glass opacity in the right lower lung subpleural fields (Fig. 4) . This report described the first typical family case of COVID-19 treated using the Chinese traditional patent medicine SHL because of poor response to other treatments. All their symptoms resolved after using the Chinese traditional patent medicine SHL and rapidly recovered without obvious adverse effects when the patients showed no response and their symptoms continued to aggravate after other treatments, including IVIG (5 g per day) and dexamethasone, antibiotics, and antivirus compounds.	./cache/cord-308673-dkmpayk4.txt	./txt/cord-308673-dkmpayk4.txt